Ropinirole

Drug Levels and Effects:




Summary of Use during Lactation:


No information is available on the use of ropinirole during breastfeeding, but it suppresses serum prolactin and may interfere with breastfeeding. An alternate drug may be preferred, especially while nursing a newborn or preterm infant.


Drug Levels:


Maternal Levels.

Relevant published information was not found as of the revision date.

Infant Levels.

Relevant published information was not found as of the revision date.


Effects in Breastfed Infants:


Relevant published information was not found as of the revision date.


Possible Effects on Lactation:


Relevant published information in nursing mothers was not found as of the revision date.Ropinirolelowers serum prolactin.[1] The prolactin level in a mother with established lactation may not affect her ability to breastfeed.


References:


1. Acton G, Broom C. A dose rising study of the safety and effects on serum prolactin of SK&F 101468, a novel dopamine d2-receptor agonist. Br J Clin Pharmacol. 1989;28:435-41. PMID:2574051



Substance Identification:




Substance Name:

Ropinirole

CAS Registry Number:

91374-21-9

Drug Class:


  • Antiparkinson Agents

  • Dopamine Agonists


  • Administrative Information:




    LactMed Record Number:


    628


    Last Revision Date:


    Disclaimer:Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.